Heart Health: Aspirin a Miracle?
“With very few exceptions, nobody is predestined to have a heart attack. Heart disease is easily preventable, but not by taking aspirin,” explains Dr. Fuhrman, but a new study links taking aspirin with lower blood pressure. Ed Edelson of HealthDay News reports:
1. U.S. Preventive Services Task Force (USPSTF) Aspirin for the Primary Prevention of Cardiovascular Events. Recommendations and rationale. January 2002. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/aspirin/asprr.htm.
2. Sanmuganathan PS, Ghahramani P, Jackson PR, et al. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomized trials. Heart 2001;85(3):265-271.
The new report is the first study to show the drug's benefit -- although only when taken at night -- with prehypertension, defined as blood pressure just below the 140/90 level. Prehypertension is a known warning sign of future risk of heart disease, stroke and other cardiovascular problems.Dr. Fuhrman doesn’t agree with all the mumbo-jumbo surrounding aspirin and heart health. He talks about it here:
Why aspirin should do its good work for blood pressure at night but not in the daytime is not clear, Hermida said. Research indicates that it can slow the production of hormones and other substances in the body that cause clotting, many of which are produced while the body is at rest.
The three-month study included 244 adults diagnosed with prehypertension. A third of them were advised to follow general rules of hygiene and diet designed to reduce blood pressure, another third were told to take a 100-milligram aspirin tablet every night at bedtime, and the final third were told to take the same aspirin dose on awakening.
Researchers monitored blood pressure levels at 20-minute intervals from 7 a.m. to 11 p.m. and at 30-minute intervals at night before the trial began and three months later.
Systolic blood pressure (the higher number in the 140/90 reading) dropped 5.4 points and diastolic pressure by 3.4 points for those taking aspirin before bedtime. No drop in blood pressure was found in those taking morning aspirin or following the general guidelines.
Five studies to date have examined the effects of daily or every-other-day aspirin use for primary prevention for periods of four to seven years.1 Most participants were men older than 50 years. Meta-analysis of the pooled data from all of the studies show that aspirin therapy reduced risk for coronary events by 28 percent, but with no decrease in mortality. In other words, aspirin use did not result in longer life. There was no reduction of death due to heart attack or stroke.I know a few people that take aspirin daily and all of them are overweight, out of shape, and take aspirin as a result of previous heart trouble. Seems like an ineffective easy way out to me.
Based on this unimpressive data, and in spite of pooled data that shows for most adults, aspirin therapy causes more harm than good,2 most Americans take it for granted that taking an aspirin every day will prevent heart disease.
Advice on aspirin for prevention against heart attacks and stroke must be based on each individual’s cardiac risk. For those at very high risk, with known risk factors such as the conventional, high-saturated fat, low-nutrient diet, high blood pressure, high cholesterol and overweight, the benefits of aspirin may outweigh the risk. But for those of us who eat healthfully, exercise and don’t smoke, taking aspirin will increase our risk of cerebral hemorrhage and other bleeding complications.
For healthy people, the risks outweigh the benefits. That is why, in contrast to typical physician recommendations aimed at reducing risk, I recommend that people eliminate their risk factors. Daily aspirin consumption is for those satisfied with mediocrity and willing to gamble with their lives.
1. U.S. Preventive Services Task Force (USPSTF) Aspirin for the Primary Prevention of Cardiovascular Events. Recommendations and rationale. January 2002. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/clinic/3rduspstf/aspirin/asprr.htm.
2. Sanmuganathan PS, Ghahramani P, Jackson PR, et al. Aspirin for primary prevention of coronary heart disease: safety and absolute benefit related to coronary risk derived from meta-analysis of randomized trials. Heart 2001;85(3):265-271.
.jpg)






